Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria

NCT00149383 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Falciparum Malaria

Interventions

DRUG: Rosiglitazone
DRUG: Placebo

Sponsor

Mahidol University

Collaborators

[object Object]